Seastar Medical Holding Revenue Growth Rates (ICU), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Seastar Medical Holding Corp  (NASDAQ: ICU)
 

ICU's Revenue Growth by Quarter and Year

Seastar Medical Holding's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ICU Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.62
1st Quarter March 0.50
FY 1.12





ICU Revenue second quarter 2026 Y/Y Growth Comment
Seastar Medical Holding Corp reported Revenue surge of 80.88% year on year in the second quarter 2026, to $ 0.62 millions, this is lower than Seastar Medical Holding Corp's recent average Revenue surge of 211.72%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 17 other companies have achieved higher Revenue growth. While Seastar Medical Holding Corp' s Revenue jump of 80.88% ranks overall at the positon no. 319 in the second quarter 2026.


ICU Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 500 % - -
3rd Quarter September - 157.14 % - -
2nd Quarter June 80.88 % - - -
1st Quarter March 72.41 % - - -
FY   - 778.57 % - -

Financial Statements
Seastar Medical Holding's second quarter 2026 Revenue $ 0.62 millions ICU's Income Statement
Seastar Medical Holding's second quarter 2025 Revenue $ 0.34 millions Quarterly ICU's Income Statement


ICU Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 133.33 % 0 % -
3rd Quarter September - -47.06 % - -
2nd Quarter June 23 % 17.24 % - -
1st Quarter March 19.05 % 314.29 % - -
FY (Year on Year)   - 778.57 % - -


Back to ICU Growth rate Comparisons >> Back to ICU Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #88
Overall #319

Revenue Y/Y Growth Statistics
High Average Low
526.87 % 211.72 % 68.94 %
(Jun 30 2026)  
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #88
Overall #319
Revenue Y/Y Growth Statistics
High Average Low
526.87 % 211.72 % 68.94 %
(Jun 30 2026)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Seastar Medical Holding's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
337.31 % 68.14 % -45.86 %
(Mar 31 2025)  


ICU's II. Quarter Q/Q Revenue Comment
Seastar Medical Holding Corp achieved in the II. Quarter 2026 below company average Revenue jump of 23% quarter on quarter, to $ 0.62 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 17.24% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Seastar Medical Holding's Revenue growth quarter on quarter, overall rank is 436.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #94
Overall #436
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #94
Overall #436
Revenue Q/Q Growth Statistics
High Average Low
337.31 % 68.14 % -45.86 %
(Mar 31 2025)  


ICU's II. Quarter Q/Q Revenue Comment
Seastar Medical Holding Corp achieved in the II. Quarter 2026 below company average Revenue jump of 23% quarter on quarter, to $ 0.62 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 17.24% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Seastar Medical Holding's Revenue growth quarter on quarter, overall rank is 436.


Seastar Medical Holding's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1.71 $ 1.44 $ 1.23 $ 0.88 $ 0.77
Y / Y Revenue Growth (TTM) 123.63 % - - - -
Year on Year Revenue Growth Overall Ranking # 133 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 19.29 % 16.37 % 40.07 % 15.01 % -
Seq. Revenue Growth (TTM) Overall Ranking # 1090 # 859 # 824 # 655 # 0


Cumulative Revenue growth Comment
With 123.63% annual Revenue growth, Seastar Medical Holding Corp would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 41 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 133.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 72
Healthcare Sector # 42
Overall # 133

Revenue TTM Y/Y Growth Statistics
High Average Low
123.63 %
 123.63 %
123.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 72
Sector # 206
S&P 500 # 1090
Cumulative Revenue growth Comment
With 123.63% annual Revenue growth, Seastar Medical Holding Corp would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 41 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 133.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 72
Healthcare Sector # 42
Overall # 133

Revenue TTM Y/Y Growth Statistics
High Average Low
123.63 %
123.63 %
123.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 72
Sector # 206
S&P 500 # 1090




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ICU's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Ataibeckley Inc 137.00%$ 136.996 millions
Pavmed Inc 135.71%$ 135.714 millions
Xilio Therapeutics Inc 131.22%$ 131.222 millions
Tenon Medical Inc 126.77%$ 126.773 millions
Sonida Senior Living Inc 122.02%$ 122.024 millions
Bridgebio Pharma Inc 120.39%$ 120.392 millions
Autolus Therapeutics Plc118.37%$ 118.367 millions
Neuraxis Inc 115.72%$ 115.717 millions
Renovorx Inc 115.40%$ 115.403 millions
Ars Pharmaceuticals Inc 114.15%$ 114.150 millions
Foghorn Therapeutics Inc 112.68%$ 112.677 millions
60 Degrees Pharmaceuticals Inc 106.04%$ 106.044 millions
Mobia Medical Inc 102.35%$ 102.352 millions
Ptc Therapeutics inc 101.55%$ 101.548 millions
Eton Pharmaceuticals Inc 98.63%$ 98.631 millions
Immunitybio inc 93.91%$ 93.907 millions
Syndax Pharmaceuticals Inc 91.76%$ 91.759 millions
Phathom Pharmaceuticals Inc 88.02%$ 88.021 millions
Fennec Pharmaceuticals Inc 85.18%$ 85.184 millions
Alamar Biosciences Inc 82.08%$ 82.075 millions
Seastar Medical Holding Corp81.95%$ 81.953 millions
Sera Prognostics Inc 76.47%$ 76.471 millions
Innovative Eyewear Inc 74.46%$ 74.459 millions
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions


About Seastar Medical Holding Revenue Growth Rates (ICU), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Seastar Medical Holding Corp (CIK 1831868).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-027353
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Seastar Medical Holding Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.